Biogen (BIIB) Other Non-Current Assets (2009 - 2026)

Biogen's Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $777.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 39.06% year-over-year to $777.5 million; the TTM figure through Mar 2026 stood at $777.5 million (up 39.06% YoY), while the FY2025 annual figure was $750.6 million, up 33.92% from the prior year.
• Other Non-Current Assets was $777.5 million for Q1 2026 at Biogen, up from $750.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.8 billion in Q1 2022 to a low of $559.1 million in Q1 2025.
• Historically, Other Non-Current Assets has averaged $965.9 million across 5 years, with a median of $750.6 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets plunged 53.21% in 2023, then surged 39.06% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $1.5 billion in 2022, then tumbled by 51.28% to $745.0 million in 2023, then fell by 24.77% to $560.5 million in 2024, then surged by 33.92% to $750.6 million in 2025, then advanced by 3.58% to $777.5 million in 2026.
• The last three Other Non-Current Assets figures came in at $777.5 million (Q1 2026), $750.6 million (Q4 2025), and $729.7 million (Q3 2025), per Business Quant data.